Androgen Deprivation Therapy Clinical Trials
0 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 2
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Prostate CancerProstate CarcinomaProstate Neoplasm+12 more
Shehzad Basaria, M.D.60 enrolled1 locationNCT06957691
Recruiting
Phase 1
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Androgen Deprivation TherapyLocally Advanced Prostate Cancer
University of Oklahoma46 enrolled1 locationNCT06130995
Recruiting
Phase 2
Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer
Androgen Deprivation TherapyProstate CA
University of Vermont32 enrolled1 locationNCT06972875
Recruiting
Not Applicable
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
Hot FlashesVasomotor SymptomsAndrogen Deprivation Therapy+2 more
Inova Health Care Services24 enrolled1 locationNCT07335224
Recruiting
Not Applicable
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
Prostate CancerProstate Cancer MetastaticAndrogen Deprivation Therapy
Dana-Farber Cancer Institute62 enrolled1 locationNCT05327465
Recruiting
Not Applicable
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
Prostate CancerMetastatic Prostate CancerAndrogen Deprivation Therapy
University of Utah74 enrolled1 locationNCT07032584
Recruiting
Phase 3
Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
Prostate CancerAndrogen Deprivation TherapyBiochemical Recurrence+2 more
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic534 enrolled17 locationsNCT05781217